114 related articles for article (PubMed ID: 28724188)
1. Bisindole-oxadiazole hybrids, T3P
Kamath PR; Joseph MM; Abdul Salam AA; Therakathinal ST; Sunil D; Biswas S; Pai KSR
J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28724188
[TBL] [Abstract][Full Text] [Related]
2. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
3. Efficient T3P
Kamath PR; Sunil D; Das S; Abdul Salam AA; Rao BS
Chem Biol Interact; 2017 Apr; 268():53-67. PubMed ID: 28235427
[TBL] [Abstract][Full Text] [Related]
4. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening, SAR, and discovery of 5-(indole-3-yl)-2-[(2-nitrophenyl)amino] [1,3,4]-oxadiazole as a novel Bcl-2 inhibitor.
Ziedan NI; Hamdy R; Cavaliere A; Kourti M; Prencipe F; Brancale A; Jones AT; Westwell AD
Chem Biol Drug Des; 2017 Jul; 90(1):147-155. PubMed ID: 28067996
[TBL] [Abstract][Full Text] [Related]
6. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.
Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N
Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916
[TBL] [Abstract][Full Text] [Related]
7. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
Kamath PR; Sunil D; Ajees AA; Pai KS; Biswas S
Eur J Med Chem; 2016 Sep; 120():134-47. PubMed ID: 27187865
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: identification of novel proapoptotic agents.
Qu HE; Huang RZ; Yao GY; Li JL; Ye MY; Wang HS; Liu L
Eur J Med Chem; 2015 May; 95():400-15. PubMed ID: 25841196
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Screening of 5-Aryl-3-(2-(pyrrolyl)thiophenyl)-1,2,4-oxadiazoles as Potential Antitumor Molecules on Breast Cancer MCF-7 Cell Line.
Abd El Hameid MK
Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1181-1195. PubMed ID: 30298827
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2.
Hamdy R; Elseginy SA; Ziedan NI; El-Sadek M; Lashin E; Jones AT; Westwell AD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256166
[TBL] [Abstract][Full Text] [Related]
11. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of quinoxaline-1,3,4-oxadiazole hybrid derivatives as potent inhibitors of the anti-apoptotic Bcl-2 protein.
Ono Y; Ninomiya M; Kaneko D; Sonawane AD; Udagawa T; Tanaka K; Nishina A; Koketsu M
Bioorg Chem; 2020 Nov; 104():104245. PubMed ID: 32911196
[TBL] [Abstract][Full Text] [Related]
13. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents.
Hamdy R; Ziedan NI; Ali S; Bordoni C; El-Sadek M; Lashin E; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2017 Feb; 27(4):1037-1040. PubMed ID: 28087272
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory growth evaluation and apoptosis induction in MCF-7 cancer cells by new 5-aryl-2-butylthio-1,3,4-oxadiazole derivatives.
Khanam R; Ahmad K; Hejazi II; Siddique IA; Kumar V; Bhat AR; Azam A; Athar F
Cancer Chemother Pharmacol; 2017 Nov; 80(5):1027-1042. PubMed ID: 28815320
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers.
Ewies EF; El-Hussieny M; El-Sayed NF; Fouad MA
Eur J Med Chem; 2019 Oct; 180():310-320. PubMed ID: 31323616
[TBL] [Abstract][Full Text] [Related]
18. Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling.
Malki A; Elbayaa RY; Ashour HM; Loffredo CA; Youssef AM
J Enzyme Inhib Med Chem; 2015; 30(5):786-95. PubMed ID: 25363687
[TBL] [Abstract][Full Text] [Related]
19. Development of 1,3,4-oxadiazole thione based novel anticancer agents: Design, synthesis and in-vitro studies.
Yadav N; Kumar P; Chhikara A; Chopra M
Biomed Pharmacother; 2017 Nov; 95():721-730. PubMed ID: 28888209
[TBL] [Abstract][Full Text] [Related]
20. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells.
Pidugu VR; Yarla NS; Bishayee A; Kalle AM; Satya AK
Apoptosis; 2017 Nov; 22(11):1394-1403. PubMed ID: 28840369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
